Single comment threadYou are looking at one branch of orforglipron vs ATTAIN — genuinely asking which matters more — 58 comments in the full submission. View in context.
1.1k
orforglipron vs ATTAIN — genuinely asking which matters more
ACHIEVE. That is the whole post, but I will justify it. Everything else people worry about in c/survodutide is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort ACHIEVE out first, and almost nobody does. I say this having got it wrong for 9 months. My eGFR…
Crossposting this to c/survodutide because the people who need it are not reading this community.
This is the "correlation is mechanism" thing again. You changed three variables at once.
Yeah, small molecule changes the whole game.
How many weeks between the two measurements?
the early fullness profile is speculative at this stage